Generic Lovenox In EU Will Require Clinical Data, Shrinking Sandoz’s Opportunity

An EU guidance issued earlier this year requiring clinical trials for generic copies of low molecular weight heparins may just have shot the European market opportunity for Momenta and its partner Sandoz, according to Momenta's CFO Rick Shea